Ladenburg Thalmann Financial Services’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-358
| Closed | -$2K | – | 5555 |
|
|
2019
Q3 | $2K | Hold |
358
| – | – | ﹤0.01% | 5026 |
|
|
2019
Q2 | $2K | Hold |
358
| – | – | ﹤0.01% | 5021 |
|
|
2019
Q1 | $5K | Sell |
358
-2
| -0.6% | -$28 | ﹤0.01% | 4687 |
|
|
2018
Q4 | $2K | Hold |
360
| – | – | ﹤0.01% | 4947 |
|
|
2018
Q3 | $4K | Buy |
360
+60
| +20% | +$667 | ﹤0.01% | 4715 |
|
|
2018
Q2 | $4K | Hold |
300
| – | – | ﹤0.01% | 4699 |
|
|
2018
Q1 | $4K | Sell |
300
-1,435
| -83% | -$19.1K | ﹤0.01% | 4699 |
|
|
2017
Q4 | $16K | Hold |
1,735
| – | – | ﹤0.01% | 3935 |
|
|
2017
Q3 | $14K | Sell |
1,735
-4,700
| -73% | -$37.9K | ﹤0.01% | 3906 |
|
|
2017
Q2 | $37K | Hold |
6,435
| – | – | ﹤0.01% | 3226 |
|
|
2017
Q1 | $28K | Buy |
6,435
+5,000
| +348% | +$21.8K | ﹤0.01% | 3330 |
|
|
2016
Q4 | $2K | Buy |
+1,435
| New | +$2K | ﹤0.01% | 4565 |
|